Orly Leiva
Impact in
- Internal Medicine top 2%
- Venous Thromboembolism Diagnosis and Management
- Genetics top 5%
- Myeloproliferative Neoplasms: Diagnosis and Treatment
Papers in
- Genetics 33
- Myeloproliferative Neoplasms: Diagnosis and Treatment 32
- Rheumatology 20
- Eosinophilic Disorders and Syndromes 18
- Co-authors
- Jean M. Connors (8 shared papers)Katya Ravid (7 shared papers)Gabriela Hobbs (30 shared papers)Hanny Al‐Samkari (5 shared papers)Christopher P. Cannon (4 shared papers)Deepak L. Bhatt (4 shared papers)Zaid Almarzooq (1 shared paper)Vipul C. Chitalia (5 shared papers)
- Journals
- Blood (8 papers)Circulation (5 papers)JACC CardioOncology (4 papers)Current Treatment Options in Oncology (3 papers)Clinical Cardiology (2 papers)
- Partner nations
- United StatesSpainNetherlands
In The Last Decade
Orly Leiva
67 papers receiving 941 citations
Peers
Comparison fields: 5 of 77
- Internal Medicine 178
- Genetics 250
- Hematology 184
- Cardiology and Cardiovascular Medicine 197
- Rheumatology 114
Countries citing papers authored by Orly Leiva
This map shows the geographic impact of Orly Leiva's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Orly Leiva with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Orly Leiva more than expected).
Fields of papers citing papers by Orly Leiva
This network shows the impact of papers produced by Orly Leiva. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Orly Leiva. The network helps show where Orly Leiva may publish in the future.
Co-authors
The 25 scholars most cited alongside Orly Leiva, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 73 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 190 | |
| 2 | 2021 | 86 | |
| 3 | 2017 | 58 | |
| 4 | 2022 | 50 | |
| 5 | 2020 | 46 | |
| 6 | 2013 | 40 | |
| 7 | 2017 | 36 | |
| 8 | 2020 | 35 | |
| 9 | 2020 | 32 | |
| 10 | 2019 | 31 | |
| 11 | 2019 | 26 | |
| 12 | 2020 | 23 | |
| 13 | 2022 | 23 | |
| 14 | 2021 | 22 | |
| 15 | 2020 | 22 | |
| 16 | 2024 | 17 | |
| 17 | 2020 | 13 | |
| 18 | 2021 | 13 | |
| 19 | 2015 | 12 | |
| 20 | 2021 | 12 |
About Orly Leiva
Orly Leiva is a scholar working on Genetics, Rheumatology, Hematology, Cardiology and Cardiovascular Medicine and Internal Medicine, having authored 73 papers that have together received 954 indexed citations. Recurring topics across this work include Myeloproliferative Neoplasms: Diagnosis and Treatment (32 papers), Eosinophilic Disorders and Syndromes (18 papers), Venous Thromboembolism Diagnosis and Management (11 papers), Chronic Myeloid Leukemia Treatments (10 papers), Chemotherapy-induced cardiotoxicity and mitigation (8 papers), Kruppel-like factors research (5 papers), Acute Myeloid Leukemia Research (5 papers) and Cardiac Imaging and Diagnostics (4 papers). The work is most often cited by research in Internal Medicine (178 citations), Genetics (250 citations), Hematology (184 citations), Cardiology and Cardiovascular Medicine (197 citations) and Rheumatology (114 citations). Orly Leiva has collaborated with scholars based in United States, Spain and Netherlands. Frequent co-authors include Jean M. Connors, Katya Ravid, Gabriela Hobbs, Hanny Al‐Samkari, Christopher P. Cannon, Deepak L. Bhatt, Zaid Almarzooq, Vipul C. Chitalia, Julia Snyder and Ruth B. Morrison. Their work appears in journals such as Blood, Circulation, JACC CardioOncology, Current Treatment Options in Oncology and Clinical Cardiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.